LYTTON LAURENCE W 13D/13G Filings for scPharmaceuticals Inc. (SCPH)

LYTTON LAURENCE W 13D and 13G filings for scPharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
3:58 pm
Purchase
2024-09-3013GscPharmaceuticals Inc.
SCPH
LYTTON LAURENCE W2,944,932
5.900%
1,119,698increase
(+61.35%)
Filing
2024-04-29
2:34 pm
Purchase
2024-04-1713GscPharmaceuticals Inc.
SCPH
LYTTON LAURENCE W1,825,234
5.100%
1,825,234increase
(New Position)
Filing